Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis
Eva M Putz, Camille Guillerey, Kevin Kos, Kimberley Stannard, Kim Miles, Rebecca B Delconte, Kazuyoshi Takeda, Sandra E Nicholson, Nicholas D Huntington, Mark J Smyth
OncoImmunology | TAYLOR & FRANCIS INC | Published : 2017
Awarded by National Health and Medical Research Council (NHMRC)
Awarded by Erwin Schroedinger Fellowship of the Austrian Science Fund
Awarded by NHMRC
This work was supported in part by the National Health and Medical Research Council (NHMRC) project grants 1049407, 1066770 and 1057852 and program grant 1016647. E.M. Putz was supported by an Erwin Schroedinger Fellowship of the Austrian Science Fund (J-3635). N. D. Huntington by a Melanoma Research Grant from the Harry J Lloyd Charitable Trust and R.B. Delconte by a Leukaemia Foundation scholarship. C. Guillerey and M.J. Smyth were supported by NHMRC Early Career (1107417) and Senior Principal Research Fellowships (1078671), respectively. This work was also supported in part by an NHMRC Independent Research Institute Infrastructure Support scheme grant and a Victorian State Government Operational Infrastructure Scheme grant.